Jan M. Werner
Jan M. Werner
University Hospital Cologne
Dirección de correo verificada de uk-koeln.de
Título
Citado por
Citado por
Año
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma
P Lohmann, P Stavrinou, K Lipke, EK Bauer, G Ceccon, JM Werner, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-12, 2018
212018
Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression
N Galldiks, M Kocher, G Ceccon, JM Werner, A Brunn, M Deckert, ...
Neuro-oncology 22 (1), 17-30, 2020
202020
Discordance and conversion rates of progesterone-, estrogen-, and HER2/neu-receptor status in primary breast cancer and brain metastasis mainly triggered by hormone therapy
M Timmer, JM Werner, G Roehn, M Ortmann, T Blau, C Cramer, ...
Anticancer research 37 (9), 4859-4865, 2017
202017
Dabrafenib treatment in a patient with an epithelioid glioblastoma and BRAF V600E mutation
G Ceccon, JM Werner, V Dunkl, C Tscherpel, G Stoffels, A Brunn, ...
International journal of molecular sciences 19 (4), 1090, 2018
192018
Combined amino acid positron emission tomography and advanced magnetic resonance imaging in glioma patients
P Lohmann, JM Werner, NJ Shah, GR Fink, KJ Langen, N Galldiks
Cancers 11 (2), 153, 2019
172019
Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI
JM Werner, G Stoffels, T Lichtenstein, J Borggrefe, P Lohmann, G Ceccon, ...
European journal of nuclear medicine and molecular imaging 46 (9), 1889-1901, 2019
152019
Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma
JM Werner, V Schweinsberg, M Schroeter, B von Reutern, MP Malter, ...
Frontiers in Oncology 9, 84, 2019
132019
Current landscape and emerging fields of pet imaging in patients with brain tumors
JM Werner, P Lohmann, GR Fink, KJ Langen, N Galldiks
Molecules 25 (6), 1471, 2020
72020
Treatment Monitoring of Immunotherapy and Targeted Therapy using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences
N Galldiks, DSY Abdulla, M Scheffler, F Wolpert, JM Werner, MW Huellner, ...
Journal of Nuclear Medicine, jnumed. 120.248278, 2020
62020
Simulation-based training of the rapid evaluation and management of acute stroke (STREAM)—a prospective single-arm multicenter trial
FO Bohmann, N Kurka, R Du Mesnil de Rochemont, K Gruber, J Guenther, ...
Frontiers in neurology 10, 969, 2019
52019
Flare Phenomenon in O-(2-18F-Fluoroethyl)-l-Tyrosine PET After Resection of Gliomas
CP Filss, AK Schmitz, G Stoffels, C Stegmayr, P Lohmann, JM Werner, ...
Journal of Nuclear Medicine 61 (9), 1294-1299, 2020
42020
Expression of FAS-L differs from primary to relapsed low-grade gliomas and predicts progression-free survival
JM Werner, S Kuhl, P Stavrinou, G Roehn, B Krischek, T Blau, ...
Anticancer research 37 (12), 6639-6648, 2017
42017
Molecular imaging and advanced MRI findings following immunotherapy in patients with brain tumors
N Galldiks, P Lohmann, JM Werner, G Ceccon, GR Fink, KJ Langen
Expert review of anticancer therapy 20 (1), 9-15, 2020
32020
Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI
N Galldiks, JM Werner, C Tscherpel, GR Fink, KJ Langen
Neuro-oncology advances 1 (1), vdz038, 2019
32019
Feature-based PET/MRI radiomics in patients with brain tumors
P Lohmann, AK Meißner, M Kocher, EK Bauer, JM Werner, GR Fink, ...
Neuro-oncology advances 2 (Supplement_4), iv15-iv21, 2020
22020
FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
P Lohmann, MA Elahmadawy, R Gutsche, JM Werner, EK Bauer, ...
Cancers 12 (12), 3835, 2020
22020
Expression of CD40 correlates negatively with overall and progression-free survival of low-and high-grade gliomas
JM Werner, S Kuhl, K Ulrich, B Krischek, P Stavrinou, R Goldbrunner, ...
World neurosurgery 130, e17-e25, 2019
22019
OS9. 6 diagnosis of pseudoprogression using FET PET radiomics
P Lohmann, MA Elahmadawy, J Werner, M Rapp, G Ceccon, GR Fink, ...
Neuro-oncology 21 (Suppl 3), iii19, 2019
22019
Death receptor 6 (DR6) Is overexpressed in astrocytomas
S Stegmann, JM Werner, S Kuhl, G Roehn, B Krischek, P Stavrinou, ...
Anticancer research 39 (5), 2299-2306, 2019
22019
Early treatment response assessment using 18F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy
G Ceccon, P Lohmann, JM Werner, C Tscherpel, V Dunkl, G Stoffels, ...
Journal of Nuclear Medicine, jnumed. 120.254243, 2020
12020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20